Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,690 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.
Aoki T, Koh K, Ikeda Y, Sekinaka Y, Akiyama K, Mori M, Arakawa Y, Hanada R. Aoki T, et al. Among authors: akiyama k. Biol Blood Marrow Transplant. 2016 Sep;22(9):1725-1728. doi: 10.1016/j.bbmt.2016.05.021. Epub 2016 May 28. Biol Blood Marrow Transplant. 2016. PMID: 27246371 Free article.
Sinusoidal obstructive syndrome prophylaxis with recombinant human soluble thrombomodulin is feasible in gemtuzumab ozogamicin-treated patients undergoing allogeneic hematopoietic cell transplantation.
Yamamoto S, Matsuno R, Sugishita Y, Kaneko R, Okamoto N, Koganesawa M, Fujita S, Akiyama K, Toyama D, Isoyama K. Yamamoto S, et al. Among authors: akiyama k. Bone Marrow Transplant. 2017 Jul;52(7):1068-1070. doi: 10.1038/bmt.2017.65. Epub 2017 Apr 3. Bone Marrow Transplant. 2017. PMID: 28368378 No abstract available.
Prophylactic recombinant thrombomodulin treatment prevents hepatic sinusoidal obstruction syndrome in high-risk pediatric patients that undergo hematopoietic stem cell transplants.
Yamamoto S, Toyama D, Sugishita Y, Kaneko R, Okamoto N, Koganesawa M, Fujita S, Akiyama K, Matsuno R, Isoyama K. Yamamoto S, et al. Among authors: akiyama k. Pediatr Transplant. 2018 Nov;22(7):e13269. doi: 10.1111/petr.13269. Epub 2018 Jul 12. Pediatr Transplant. 2018. PMID: 30003636
Successful Treatment of Pediatric Refractory/Relapsed AML with KIR-Ligand-Mismatched Cord Blood Transplant after FLAG-IDA Reinduction Therapy with or without the GO Regimen.
Toyama D, Matsuno R, Sugishita Y, Kaneko R, Okamoto N, Koganesawa M, Fujita S, Akiyama K, Isoyama K, Yamamoto S. Toyama D, et al. Among authors: akiyama k. Case Rep Hematol. 2020 Feb 12;2020:1378056. doi: 10.1155/2020/1378056. eCollection 2020. Case Rep Hematol. 2020. PMID: 32099697 Free PMC article.
1,690 results